Valere Therapeutics
Where advanced immunotherapy meets regional impact and global ambition
An immune cell (orange) attacking and destroying a cancer cell (green) - a powerful glimpse into the science behind Valere Therapeutics’ mission to harness the body’s defences against cancer.
Our Concept
Breast cancer remains the most common cancer among women in Saudi Arabia, placing a heavy medical and economic burden on patients and healthcare systems. Current treatments often fall short for aggressive forms like triple-negative breast cancer, leaving a critical need for more effective and accessible options.
At Valere Therapeutics, we are developing and locally manufacturing next-generation immunotherapies that are more robust, personalised, and cost-effective than today’s standard of care. By bridging global innovation with local capability, we aim to deliver transformative cancer treatments that empower patients across the Gulf region and redefine the future of cancer care worldwide.
Our Mission
To develop effective, accessible immunotherapies for the world’s toughest cancers.
​
Our Vision
To position the GCC as a hub for next-generation immunotherapy, developing transformative science locally and delivering it globally. ​
What We’re Building
We are now entering the proof-of-concept development phase, where we will validate our technology and bring our first immunotherapy candidates to life. We are seeking strategic partners and investors who share our vision to make cutting-edge cancer care more accessible, starting in the Gulf region. Together, we can turn innovation into impact.
